Since Health Canada announced last week that Pfizer-BioNTech is seeking authorization for its COVID-19 vaccine for younger children, many people have been asking questions. Here’s what we’ve been able to find out:
What do we know about Pfizer’s pediatric COVID-19 vaccine?
Pfizer-BioNTech is the first company to seek Health Canada’s approval for a pediatric COVID-19 vaccine (although other companies, such as Moderna, are working on children’s formulations).
The pediatric version of the vaccine is for kids age five to 11. Those 12 and older get the already approved adult formulation.
The pediatric formulation will be given in smaller doses — 10 mcg (micrograms) instead of the
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/health/covid-pfizer-vaccination-younger-kids-canada-1.6219545?cmp=rss.